{"log_id": 7290915385573588800, "direction": 0, "words_result_num": 61, "words_result": [{"probability": {"variance": 0.008092, "average": 0.973011, "min": 0.583144}, "location": {"width": 403, "top": 151, "height": 31, "left": 205}, "words": "儿用药:尚无儿童使用该药的药代动力学数据"}, {"probability": {"variance": 1.2e-05, "average": 0.997254, "min": 0.991123}, "location": {"width": 102, "top": 194, "height": 24, "left": 199}, "words": "[临床研究]"}, {"probability": {"variance": 0.002099, "average": 0.975034, "min": 0.866013}, "location": {"width": 141, "top": 233, "height": 26, "left": 198}, "words": "国内的临床试验"}, {"probability": {"variance": 3.8e-05, "average": 0.993222, "min": 0.979969}, "location": {"width": 301, "top": 272, "height": 26, "left": 198}, "words": "核苷类药物初治患者(肝功能代偿)"}, {"probability": {"variance": 0.014754, "average": 0.957471, "min": 0.423037}, "location": {"width": 721, "top": 303, "height": 37, "left": 242}, "words": "A463023是一项随机双的研究,在519名核苷类药物初治慢性乙肝患者中,比较了"}, {"probability": {"variance": 0, "average": 0.996861, "min": 0.996861}, "location": {"width": 25, "top": 299, "height": 23, "left": 1086}, "words": "药"}, {"probability": {"variance": 0.026086, "average": 0.929879, "min": 0.366614}, "location": {"width": 754, "top": 342, "height": 38, "left": 194}, "words": "服用0.5mg/天思卡100mg/天拉米夫定48周的疗效。患者的平均年龄为30岁(16"}, {"probability": {"variance": 0, "average": 0.90301, "min": 0.90301}, "location": {"width": 24, "top": 335, "height": 24, "left": 1082}, "words": "t"}, {"probability": {"variance": 0.020572, "average": 0.927284, "min": 0.461476}, "location": {"width": 357, "top": 387, "height": 31, "left": 193}, "words": "fd岁),79%为男性,15%的患者曾接受过"}, {"probability": {"variance": 0.014675, "average": 0.926916, "min": 0.605703}, "location": {"width": 364, "top": 383, "height": 27, "left": 599}, "words": "干扰素治疗。治疗前,志者平均血 HBV DNA"}, {"probability": {"variance": 0.01452, "average": 0.938216, "min": 0.54405}, "location": {"width": 771, "top": 419, "height": 39, "left": 192}, "words": "基线水平为8.5610Em贝/mL(PCR法),平均血清ALT基线水平为197U/L,月有86%的"}, {"probability": {"variance": 0.011823, "average": 0.932919, "min": 0.525372}, "location": {"width": 760, "top": 459, "height": 38, "left": 191}, "words": "志者为 HBEAG阳性,恩替卡韦在主要疗效终点(在第48周bDN法检验 HBV DNA<0.7MEq/mL"}, {"probability": {"variance": 0.007688, "average": 0.951219, "min": 0.622341}, "location": {"width": 569, "top": 500, "height": 36, "left": 191}, "words": "ALT<1.25XULN)优于拉米夫定、生化、病毒学和血清学结果见表1"}, {"probability": {"variance": 0.001568, "average": 0.977795, "min": 0.811078}, "location": {"width": 706, "top": 561, "height": 39, "left": 187}, "words": "表1:核苷类药物初治患者试验第48周的生化、病毒学和血清学结果(AI463023)"}, {"probability": {"variance": 0.01108, "average": 0.946904, "min": 0.672188}, "location": {"width": 205, "top": 605, "height": 26, "left": 611}, "words": "恩替卡韦拉米夫定"}, {"probability": {"variance": 0, "average": 0.999699, "min": 0.999472}, "location": {"width": 46, "top": 602, "height": 24, "left": 940}, "words": "差值"}, {"probability": {"variance": 8.2e-05, "average": 0.991539, "min": 0.976091}, "location": {"width": 46, "top": 637, "height": 19, "left": 623}, "words": "0.5m"}, {"probability": {"variance": 0.005977, "average": 0.950288, "min": 0.749116}, "location": {"width": 312, "top": 626, "height": 29, "left": 749}, "words": "100mg思替卡韦拉米夫定"}, {"probability": {"variance": 0.000463, "average": 0.983124, "min": 0.931808}, "location": {"width": 161, "top": 655, "height": 23, "left": 883}, "words": "95%可信区间)P值"}, {"probability": {"variance": 3.1e-05, "average": 0.994155, "min": 0.988547}, "location": {"width": 22, "top": 685, "height": 21, "left": 746}, "words": "26"}, {"probability": {"variance": 0, "average": 0.999681, "min": 0.999426}, "location": {"width": 42, "top": 682, "height": 24, "left": 843}, "words": "总数"}, {"probability": {"variance": 3.3e-05, "average": 0.995551, "min": 0.983887}, "location": {"width": 123, "top": 717, "height": 28, "left": 184}, "words": "综合疗效终点"}, {"probability": {"variance": 1.7e-05, "average": 0.994206, "min": 0.990835}, "location": {"width": 42, "top": 714, "height": 21, "left": 593}, "words": "90%"}, {"probability": {"variance": 0.000465, "average": 0.984162, "min": 0.95367}, "location": {"width": 39, "top": 711, "height": 21, "left": 726}, "words": "67%"}, {"probability": {"variance": 0.005096, "average": 0.966898, "min": 0.731565}, "location": {"width": 150, "top": 707, "height": 28, "left": 842}, "words": "23.1(16.3,29.9)"}, {"probability": {"variance": 0.000177, "average": 0.987995, "min": 0.956744}, "location": {"width": 74, "top": 738, "height": 17, "left": 840}, "words": "P<0.000"}, {"probability": {"variance": 0.042473, "average": 0.845381, "min": 0.494664}, "location": {"width": 180, "top": 770, "height": 25, "left": 185}, "words": "ALT复常(≤1XILN)"}, {"probability": {"variance": 1.3e-05, "average": 0.996747, "min": 0.991804}, "location": {"width": 41, "top": 765, "height": 21, "left": 592}, "words": "90%"}, {"probability": {"variance": 7.6e-05, "average": 0.9921, "min": 0.979908}, "location": {"width": 41, "top": 764, "height": 19, "left": 723}, "words": "78%"}, {"probability": {"variance": 0.001573, "average": 0.976167, "min": 0.854809}, "location": {"width": 136, "top": 759, "height": 22, "left": 844}, "words": "10.3(4.6,16.0)"}, {"probability": {"variance": 0.001158, "average": 0.981594, "min": 0.893254}, "location": {"width": 76, "top": 787, "height": 19, "left": 845}, "words": "P=0.0005"}, {"probability": {"variance": 0.000127, "average": 0.983654, "min": 0.972398}, "location": {"width": 66, "top": 823, "height": 22, "left": 183}, "words": " HBV DNA"}, {"probability": {"variance": 0.017616, "average": 0.917809, "min": 0.509847}, "location": {"width": 421, "top": 839, "height": 34, "left": 221}, "words": " HBV DNA相对于基线值的平均改变(Iog和-5.90"}, {"probability": {"variance": 9.2e-05, "average": 0.990845, "min": 0.974292}, "location": {"width": 46, "top": 840, "height": 21, "left": 725}, "words": "4.33"}, {"probability": {"variance": 0.003546, "average": 0.963282, "min": 0.794103}, "location": {"width": 163, "top": 835, "height": 26, "left": 844}, "words": "1.50(-1.77,-1.2)"}, {"probability": {"variance": 0.000711, "average": 0.982543, "min": 0.901238}, "location": {"width": 167, "top": 874, "height": 24, "left": 219}, "words": "拷贝/mL)(PCR法)"}, {"probability": {"variance": 0.004201, "average": 0.951152, "min": 0.818294}, "location": {"width": 66, "top": 865, "height": 18, "left": 840}, "words": "P<0.000"}, {"probability": {"variance": 0.016627, "average": 0.895566, "min": 0.477594}, "location": {"width": 316, "top": 892, "height": 36, "left": 217}, "words": " HBV DNA01gu拷贝/mL)(PCR法"}, {"probability": {"variance": 0.000266, "average": 0.989177, "min": 0.939266}, "location": {"width": 150, "top": 887, "height": 23, "left": 839}, "words": "34.6(27.0,42.2)"}, {"probability": {"variance": 0.006523, "average": 0.950682, "min": 0.759421}, "location": {"width": 75, "top": 915, "height": 20, "left": 838}, "words": "P<0.000"}, {"probability": {"variance": 0.039336, "average": 0.822285, "min": 0.413554}, "location": {"width": 270, "top": 942, "height": 32, "left": 217}, "words": " HBV DNA<C.7HgmL(bDM法)"}, {"probability": {"variance": 0.000262, "average": 0.987282, "min": 0.95541}, "location": {"width": 156, "top": 941, "height": 25, "left": 587}, "words": "95%72"}, {"probability": {"variance": 0.02938, "average": 0.911291, "min": 0.504907}, "location": {"width": 154, "top": 937, "height": 24, "left": 839}, "words": "22.8(16.7,28,9)"}, {"probability": {"variance": 0.011155, "average": 0.906107, "min": 0.701492}, "location": {"width": 75, "top": 967, "height": 17, "left": 838}, "words": "P<0.0001"}, {"probability": {"variance": 0.000498, "average": 0.970575, "min": 0.944458}, "location": {"width": 103, "top": 1001, "height": 24, "left": 180}, "words": " Hbeag消失"}, {"probability": {"variance": 0.001114, "average": 0.97655, "min": 0.896372}, "location": {"width": 133, "top": 989, "height": 21, "left": 845}, "words": "1.7(-9.0.5.6)"}, {"probability": {"variance": 3.7e-05, "average": 0.992423, "min": 0.981432}, "location": {"width": 63, "top": 1016, "height": 20, "left": 837}, "words": "P=0.65"}, {"probability": {"variance": 0.007822, "average": 0.938456, "min": 0.767215}, "location": {"width": 141, "top": 1051, "height": 25, "left": 178}, "words": " HBEAG血清转换"}, {"probability": {"variance": 0.004414, "average": 0.924536, "min": 0.8581}, "location": {"width": 21, "top": 1048, "height": 21, "left": 588}, "words": "15"}, {"probability": {"variance": 0.020723, "average": 0.833904, "min": 0.689948}, "location": {"width": 18, "top": 1045, "height": 19, "left": 723}, "words": "18"}, {"probability": {"variance": 0.001934, "average": 0.969136, "min": 0.856214}, "location": {"width": 136, "top": 1040, "height": 24, "left": 841}, "words": "-3.0(-9.8,3.8)"}, {"probability": {"variance": 3.3e-05, "average": 0.992933, "min": 0.983737}, "location": {"width": 51, "top": 1068, "height": 20, "left": 849}, "words": "=0.39"}, {"probability": {"variance": 0.016924, "average": 0.922683, "min": 0.450596}, "location": {"width": 761, "top": 1090, "height": 45, "left": 183}, "words": "综合疗效终点:在第48周时,bDNA法检测 HBY DN0.7MEg/mL,并且血ALT<1.25XULN"}, {"probability": {"variance": 0.002138, "average": 0.978865, "min": 0.828577}, "location": {"width": 275, "top": 1142, "height": 28, "left": 183}, "words": "差值按基线 HBEAG状态分层分析"}, {"probability": {"variance": 0.012232, "average": 0.935464, "min": 0.541321}, "location": {"width": 640, "top": 1170, "height": 43, "left": 180}, "words": "值基于基线 HBV DNA水平(PCR法)与 HBEAG状态校正后的线形回归模型"}, {"probability": {"variance": 0.044918, "average": 0.874462, "min": 0.458536}, "location": {"width": 235, "top": 1219, "height": 32, "left": 182}, "words": "在基线 HBEAG阳性的受试者"}, {"probability": {"variance": 0.013828, "average": 0.945314, "min": 0.511006}, "location": {"width": 339, "top": 1283, "height": 31, "left": 173}, "words": "拉米夫定治疗失效的患者(肝功能代偿)"}, {"probability": {"variance": 0.013966, "average": 0.935366, "min": 0.466152}, "location": {"width": 732, "top": 1309, "height": 43, "left": 219}, "words": "A463056是一项随机双言的研究,在133名拉来夫定治疗失效的 Hbeag阳性和阴性的"}, {"probability": {"variance": 0.026047, "average": 0.932137, "min": 0.35691}, "location": {"width": 760, "top": 1344, "height": 43, "left": 172}, "words": "慢性乙肝患者中,比较了服用1.0mg/天思替卡韦与安慰12周的疗效在双给药阶段"}, {"probability": {"variance": 0.020816, "average": 0.921068, "min": 0.382073}, "location": {"width": 778, "top": 1380, "height": 47, "left": 172}, "words": "患者被随机分组(4:1)服用恩替卡韦1.0mg或安慰剂治疗12周后,所有的受试者继续接"}, {"probability": {"variance": 0.016968, "average": 0.932173, "min": 0.523921}, "location": {"width": 777, "top": 1420, "height": 44, "left": 172}, "words": "受为期36周的开放期治疗,在开放期内,受试者报用1.0mg/天思替卡韦,患者的平均年龄"}], "language": 3}